Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN DG ENERGY INCADGE · Entity 175763 | Director | May 23, 2017 | May 25, 2017 |
| TECOGEN INC.TGEN · Entity 6846 | Director | July 09, 2020 | July 21, 2020 |
| Tectonic Therapeutic, Inc.AVRO · Entity 5328 | Chief Business Officer | February 08, 2023 | February 10, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN DG ENERGY INC
Report date May 23, 2017 · Filed May 25, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-05-23 transaction · row 1
1 source rowRow 1 · 2017-05-23 · Other · Disposed 60,507 · Balance 0 F1: Following the completion of the Merger and pursuant to the Merger Agreement between the Company and Tecogen Inc. dated November 1, 2016 and as amended March 23, 2017, the Company's securities were converted to securities of the Tecogen Inc. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.32 · Expires 2026-04-05 | Direct | 0 |
Reported balance
After 2017-05-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-05-23 · Other · Disposed 100,000 · Balance 0 F1: Following the completion of the Merger and pursuant to the Merger Agreement between the Company and Tecogen Inc. dated November 1, 2016 and as amended March 23, 2017, the Company's securities were converted to securities of the Tecogen Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Following the completion of the Merger and pursuant to the Merger Agreement between the Company and Tecogen Inc. dated November 1, 2016 and as amended March 23, 2017, the Company's securities were converted to securities of the Tecogen Inc.
TECOGEN INC.
Report date July 09, 2020 · Filed July 21, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.71 · Expires 2030-07-09 | Direct | 109,200 |
Reported balance
After 2020-07-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-07-09 · Grant · Acquired 100,000 · Balance 109,200 F1: 25% of options vest on each of the first four anniversaries of the grant date |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of options vest on each of the first four anniversaries of the grant date
Tectonic Therapeutic, Inc.
Report date February 08, 2023 · Filed February 10, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-02-01 | Direct | 86,667 |
Reported balance
After 2023-02-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-02-08 · Grant · Acquired 86,667 · Balance 86,667 F1: The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2023 Filed Feb 10, 2023 17:16 UTC | Tectonic Therapeutic, Inc. AVRO · Entity 5328 | GrantRestricted Stock Unit · Derivative | 86,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004515 · form4.xml · derivative · entry 1 Petersen Deanna M · CIK 0001493139 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,667 Underlying: Common Stock · 86,667 shares Expires 2027-02-01 F1 · derivative.exercise_date: The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 17:31 UTC | Tectonic Therapeutic, Inc. AVRO · Entity 5328 | GrantStock Option (Right to Buy) · Derivative | 111,500 | $0.00 Strike: $0.79 | $0.00 |
DisclosureSEC source: 0001127602-22-027236 · form4.xml · derivative · entry 1 Petersen Deanna M · CIK 0001493139 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,500 Underlying: Common Stock · 111,500 shares Expires 2032-12-07 F1 · derivative.exercise_date: 50% of the shares shall vest and become exercisable on the first anniversary of the grant date, and the remaining 50% shall vest in equal monthly installments thereafter over a one-year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 17:24 UTC | Tectonic Therapeutic, Inc. AVRO · Entity 5328 | GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001127602-22-003428 · form4.xml · derivative · entry 2 Petersen Deanna M · CIK 0001493139 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: 25% of the shares shall vest and become exercisable on February 2, 2023, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 17:24 UTC | Tectonic Therapeutic, Inc. AVRO · Entity 5328 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001127602-22-003428 · form4.xml · derivative · entry 1 Petersen Deanna M · CIK 0001493139 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: 25% of the shares shall vest and become exercisable on February 2, 2023, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 18:06 UTC | Tectonic Therapeutic, Inc. AVRO · Entity 5328 | GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $9.63 | $0.00 |
DisclosureSEC source: 0001127602-21-019840 · form4.xml · derivative · entry 1 Petersen Deanna M · CIK 0001493139 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: 50% of the shares shall vest and become exercisable on June 10, 2023, and the remaining 50% shall vest and become exercisable on June 10, 2024. Read SEC document |
| February 04, 2021 Filed Feb 4, 2021 17:53 UTC | Tectonic Therapeutic, Inc. AVRO · Entity 5328 | GrantStock Option (Right to Buy) · Derivative | 86,600 | $0.00 Strike: $16.02 | $0.00 |
DisclosureSEC source: 0001127602-21-004041 · form4.xml · derivative · entry 1 Petersen Deanna M · CIK 0001493139 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,600 Underlying: Common Stock · 86,600 shares Expires 2031-02-03 F1 · derivative.exercise_date: 25% of the shares shall vest and become exercisable on February 4, 2022, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period. Read SEC document |
| July 09, 2020 Filed Jul 21, 2020 11:46 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.71 Strike: $0.71 | $71,000.00 |
DisclosureSEC source: 0001537435-20-000094 · wf-form4_159534634868261.xml · derivative · entry 1 Petersen Deanna M · CIK 0001493139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,200 Underlying: Common Stock · 100,000 shares Expires 2030-07-09 F1 · derivative.exercise_date: 25% of options vest on each of the first four anniversaries of the grant date Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 16:41 UTC | Tectonic Therapeutic, Inc. AVRO · Entity 5328 | GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $21.44 | $0.00 |
DisclosureSEC source: 0001127602-20-009843 · form4.xml · derivative · entry 1 Petersen Deanna M · CIK 0001493139 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2030-03-03 F1 · derivative.exercise_date: 25% of the shares shall vest and become exercisable on February 3, 2021, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:51 UTC | AMERICAN DG ENERGY INC ADGE · Entity 175763 | OtherStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.32 | $0.00 |
DisclosureSEC source: 0001378706-17-000050 · wf-form4_149576347465419.xml · derivative · entry 2 Petersen Deanna M · CIK 0001493139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2026-04-05 F1 · kind: Following the completion of the Merger and pursuant to the Merger Agreement between the Company and Tecogen Inc. dated November 1, 2016 and as amended March 23, 2017, the Company's securities were converted to securities of the Tecogen Inc. F1 · derivative.exercise_date: Following the completion of the Merger and pursuant to the Merger Agreement between the Company and Tecogen Inc. dated November 1, 2016 and as amended March 23, 2017, the Company's securities were converted to securities of the Tecogen Inc. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:51 UTC | AMERICAN DG ENERGY INC ADGE · Entity 175763 | OtherCommon Stock | 60,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001378706-17-000050 · wf-form4_149576347465419.xml · nonDerivative · entry 1 Petersen Deanna M · CIK 0001493139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Following the completion of the Merger and pursuant to the Merger Agreement between the Company and Tecogen Inc. dated November 1, 2016 and as amended March 23, 2017, the Company's securities were converted to securities of the Tecogen Inc. Read SEC document |
| April 05, 2016 Filed Mar 15, 2017 16:54 UTC | AMERICAN DG ENERGY INC ADGE · Entity 175763 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.32 Strike: $0.32 | $32,000.00 |
DisclosureSEC source: 0001378706-17-000006 · wf-form5_148961125462369.xml · derivative · entry 1 Petersen Deanna M · CIK 0001493139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Stock Option (right to buy) · 100,000 shares Expires 2026-04-05 F1 · shares: 25% of these options vest on each of the 4 subsequent anniversaries of the grant date. F2 · derivative.exercise_date: This Form 5 is being filed late due to a mistake by the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.